Anti-DDAH2 antibody,Abcam,AB232694

Host

Rabbit

Reactivity

Human, Pig

Application

WB, IHC-P

Platform ID

BAB529135302

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-DDAH2 antibody
Cat. No.AB232694
HostRabbit
IsotypeIgG
ReactivityHuman, Pig
ApplicationWB, IHC-P
ClonalityPolyclonal
Concentration0.92 mg/mL Batch dependent concentration
ImmunogenRecombinant Fragment Protein within Human DDAH2 aa 1 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 55.77% Glycerol (glycerin, glycerine)
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Putative hydrolase with unknown substrate (Probable). Does not hydrolyze N(G),N(G)-dimethyl-L-arginine (ADMA) which acts as an inhibitor of NOS (PubMed : 21493890, PubMed : 37296100). In endothelial cells, induces expression of vascular endothelial growth factor (VEGF) via phosphorylation of the transcription factor SP1 by PKA in a process that is independent of NO and NO synthase (By similarity). Similarly, enhances pancreatic insulin secretion through SP1-mediated transcriptional up-regulation of secretagogin/SCGN, an insulin vesicle docking protein (By similarity). Upon viral infection, relocates to mitochondria where it promotes mitochondrial fission through activation of DNM1L leading to the inhibition of innate response activation mediated by MAVS (PubMed : 33850055). See full target information DDAH2

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.